Qube Research & Technologies LTD Mei Pharma, Inc. Transaction History

Qube Research & Technologies LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.41 - $0.64 $576 - $899	1,406 Added 1.51%	94,438 $37,000
Q2 2022 Aug 15, 2022	BUY	$0.42 - $0.65 $39,073 - $60,470	93,032 New	93,032 $56,000
Q4 2020 Feb 16, 2021	SELL	$2.6 - $3.32 $96,603 - $123,354	-37,155 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$2.46 - $4.27 $64,626 - $112,177	26,271 Added 241.37%	37,155 $116,000
Q2 2020 Aug 14, 2020	BUY	$1.45 - $4.3 $15,781 - $46,801	10,884 New	10,884 $45,000

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $373M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.